sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastiske midler - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
cytarabine accord 20 mg/ ml
accord healthcare b.v. - cytarabin - injeksjons-/infusjonsvæske, oppløsning - 20 mg/ ml
pregabalin accord
accord healthcare s.l.u. - pregabalin - anxiety disorders; epilepsy - antiepileptics, - epilepsypregabalin accord er indisert som tilleggsbehandling hos voksne med partielle anfall med eller uten sekundær generalisering. generell angst disorderpregabalin accord er angitt for behandling av generalisert angstlidelse (gad) i voksne.
cisplatin accord 1 mg/ ml
accord healthcare b.v. - cisplatin - konsentrat til infusjonsvæske, oppløsning - 1 mg/ ml
gemcitabine accord 100 mg/ ml
accord healthcare b.v. - gemcitabinhydroklorid - konsentrat til infusjonsvæske, oppløsning - 100 mg/ ml
quetiapine accord 200 mg
accord healthcare b.v. - kvetiapinfumarat - depottablett - 200 mg
quetiapine accord 300 mg
accord healthcare b.v. - kvetiapinfumarat - depottablett - 300 mg
quetiapine accord 400 mg
accord healthcare b.v. - kvetiapinfumarat - depottablett - 400 mg
sertraline accord 50 mg
accord healthcare b.v. - sertralinhydroklorid - tablett, filmdrasjert - 50 mg
sertraline accord 100 mg
accord healthcare b.v. - sertralinhydroklorid - tablett, filmdrasjert - 100 mg